…reference on inpatient insulin therapy Peptic ulcer A proton pump inhibitor with concomitant NSAID use or a history of ulcer, not routinely Infection Consider Pneumocystis…

…competitive athletics. In the context of Brugada syndrome (BrS), pharmacologic challenge with sodium channel blockers (ajmaline or flecainide) is utilized for diagnostic unmasking; if ventricula

…consideration for patients with low blood pressure secondary to a low cardiac output. Its primary clinical utility in contemporary practice is late line therapy for…

…Adults with blood pressure ≥140/90 mmHg should receive both lifestyle and antihypertensive drug therapy. For grade 1 hypertension, pharmacological treatment has demonstrated cardiovascular benefit…

Cardiology Pharmacology & dosing Definition and pathophysiology Lipid lowering therapy is a central component of cardiovascular prevention, particularly in patients with established atherosclerotic cardiovascular disease (ASCVD…

…antianginal drugs have not been shown to improve long term cardiovascular outcomes in CCS. General strategy For most patients, initial therapy consists of a beta…

…sex. P2Y12 inhibitor monotherapy A P2Y12 inhibitor may be used instead of aspirin for long term secondary prevention, particularly when aspirin is contraindicated, not tolerated…

…3 month DAPT, but not 6 month DAPT, was associated with higher rates of myocardial infarction or stent thrombosis in ACS patients. Extension beyond 12…

…also an appropriate first line pharmacological option when a patient is unable to tolerate any statin regimen. The treatment sequence for patients with chronic coronary…

…at a particular symptom complex. The source material does not describe a characteristic symptom profile at initiation or during routine therapy. Potential clinically important complications…